Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): Surgical risk and long-term results
Bariatric surgery is the most effective therapy for patients with morbid obesity today [1]. However, the types of operation are still evolving. Sleeve gastrectomy (SG) recently has quickly gained popularity as a primary bariatric surgery worldwide [2,3]. SG plus duodeno-jejunostomy (SG-DJB) was introduced in 2007 as an alternative to Roux-en-Y gastric bypass (RYGB) because the issue of gastric cancer arising from the excluded stomach [4]. SG-DJB can be regarded as a modification of duodenal switch (DS) with short bypass limb and fewer nutritional problems [5].
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Kong-Han Ser, Wei-Jei Lee, Jung-Chien Chen, Pei-Ling Tsai, Shu-Chun Chun, Yi-Chih Lee Tags: Original article Source Type: research
More News: Bariatric Surgery | Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Gastrectomy | Gastric (Stomach) Cancer | Gastric Bypass | Gastroenterology | Laparoscopy | Nutrition | Obesity | Surgery